Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Accessory gene regulator (Agr) quorum-sensing system is the master controller of virulence in Staphylococcus aureus, coordinating the expression of toxins and enzymes in response to bacterial population density (Novick & Geisinger, 2008, PubMed). The system operates via a four-gene operon (agrACDB) that produces and detects a signaling molecule known as the autoinducing peptide (AIP) (Wang & Muir, 2016, Journal of Biological Chemistry). When AIP reaches a threshold concentration, it activates the AgrC-AgrA two-component system, triggering the production of RNAIII, the primary effector molecule of the Agr system (Queck et al., 2008, Molecular Cell). RNAIII subsequently upregulates the production of secreted virulence factors, such as alpha-hemolysin and proteases, while downregulating surface-adhesion proteins (Recsei et al., 1986, Nature). This transition is crucial for the pathogen's ability to escape the host immune response and spread from localized infections to systemic disease (Gordon et al., 2013, Journal of Infectious Diseases). Because the Agr system is essential for pathogenesis but not for bacterial growth, it is a prime target for anti-virulence therapies designed to attenuate infection without exerting the strong selective pressure that leads to antibiotic resistance (Sully et al., 2014, PLOS Pathogens). Small molecules like Savirin and various AIP analogs have been developed to disrupt this signaling pathway, demonstrating efficacy in reducing tissue damage in animal models (Sully et al., 2014, PLOS Pathogens).
Inhibition of the AgrA response regulator DNA-binding activity, competitive antagonism of the AgrC sensor kinase by autoinducing peptide (AIP) analogs, or interference with the AgrB-mediated processing of the signaling peptide (Sully et al., 2014, PLOS Pathogens; Wang & Muir, 2016, Journal of Biological Chemistry).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Accessory gene regulator quorum-sensing system (Agr system) (Agr).